-
EDITORIAL
The Fictional Chemist?
I. Grayson
-
ANALYTICAL TECHNOLOGIES
Mass Spectrometry in characterising biopharmaceuticals
J. Hoefkens, A. Ceroni, P. Haberl, A. Taylor
-
ANALYTICAL TECHNOLOGIES
Why development of new HPLC column technology is still alive
J. E. Young, M. T. Matyska, J. J. Pesek
Stationary phase innovations rise to meet the demands of modern chromatographers
-
NEWS - PEPTIDES
News – Peptides
-
HPAIs
Carryover and occupational exposure limits: can they be correlated?
E. Lovsin Barle, M. A. Cudd, R. Looser, R. Bechter, G. C. Winkler
-
HPAIs
Potent compound safety in the laboratory
J. P. Farris, J. J. Mason-Home
-
HPAIs
Practical containment – how to address and solve HAPI containment challenges
T. Belger
-
CONTRACT MANUFACTURING
How venture capital finds you
C. Wyss
-
REGULATION
EU regulatory frameworks and pharmaceutical law
P. Feldschreiber
-
REGULATION
“Reach” ing an agreement on data sharing
G. A. Towell
-
CATALYSIS
Hydrophobicityon the kinetics of acid-catalyzed aquation of pyridyl-imines iron(II)
M. S. S. Adam, Ahmad Desoky M. M.
complexes in aqueous and binary aqueous methanolmixtures
-
NANOTECHNOLOGIES
Medical nanotechnology: the obstacles hampering a future dominant market
R. Bosetti
-
ENZYMATIC MICROREACTORS
Enzymatic microreactors utilizing non-aqueous media
P. Žnidaršic-Plazl
-
EVENTS
Events
-
News
News
